Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO
Published May 2025 · Last reviewed May 2026
The Med Device Cyber Podcast · May 1, 2025 This episode of "The Med Device Cyber Podcast" navigates the intricate regulatory landscape governing medical devices, focusing on cybersecurity. Hosts Trevor and Christian Espinosa of BluCyber discuss the critical shift towards integrating cybersecurity early in the product development lifecycle, rather than as a reactive add-on. They categorize medical device manufacturers into startups and large companies, highlighting common pitfalls where cybersecurity is neglected until late in the submission process, leading to delays and significant rework. The discussion thoroughly explores the primary regulatory bodies, specifically the FDA and EU MDR, emphasizing the impact of the FDA's February 2026 guidance which has led to increased submission rejections due to inadequate cybersecurity planning. The episode distinguishes between pre-market and post-market requirements, detailing the FDA's device classification system (Class 1, 2, and 3) based on risk. It also clarifies different pre-market submission types like 510K, PMA, and De Novo. A compelling case study of a Class 2 laser acne treatment device demonstrates the severe patient safety risks posed by cybersecurity vulnerabilities, even in seemingly benign devices, underscoring the necessity of stringent testing following frameworks like UL 2900 or IEC 62304. This episode is essential listening for product security teams, regulatory affairs professionals, and engineers seeking to understand and proactively address medical device cybersecurity compliance.
Key Takeaways
- Early integration of cybersecurity into medical device design is crucial to prevent costly retrofitting and regulatory delays.
- The FDA's February 2026 guidance significantly elevated cybersecurity requirements for medical device submissions, leading to increased rejections for non-compliance.
- Medical devices are classified (Class 1, 2, 3) based on patient risk, with higher classifications requiring more stringent cybersecurity controls.
- Pre-market submissions (510K, PMA, De Novo) and post-market surveillance are both critical components of medical device cybersecurity compliance.
- Even seemingly low-risk devices can pose significant patient harm if cybersecurity vulnerabilities are exploited.
- Adherence to medical device-specific testing frameworks, such as UL 2900 or IEC 62304, is vital for proper penetration testing and regulatory approval.
Listen on mdcpodcast.com · Watch on YouTube
Listen to this episode
Want help applying this to your own device program?
Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.